This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignee: Cephalon, Inc.. Active years: 1996-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wallingford, PA (US) (1996 - 2000)
- West Chester, PA (US) (2001 - 2004)
Company Filing History:
Years Active: 1996-2004
Title: The Innovations of Richard W. Scott
Introduction
Richard W. Scott is a notable inventor based in Wallingford, PA (US). He has made significant contributions to the field of biomedical research, particularly in the study of Alzheimer's disease. With a total of 7 patents to his name, Scott's work has had a profound impact on the understanding and treatment of neurodegenerative disorders.
Latest Patents
Among his latest patents, Scott has developed a gene-targeted non-human mammal with a human FAD presenilin mutation and generational offspring. This invention provides a gene-targeted, non-human mammal that encodes a mutant protein product of a mutated FAD presenilin-1 (PS-1) gene, incorporating a human FAD Swedish mutation and a humanized Aβ mutation. Additionally, it includes methods for identifying compounds useful in treating Alzheimer's disease. Another significant patent involves a gene-targeted non-human mammal with respect to the gene encoding a mutant protein product of a mutated presenilin 1 gene (PS-1), specifically a gene-targeted mouse with the human P264L mutation. This invention also discloses methods for screening chemical compounds using such mammals.
Career Highlights
Richard W. Scott has been associated with Cephalon, Inc., where he has contributed to various innovative projects. His work has focused on developing models that can aid in the understanding of Alzheimer's disease and potential treatments.
Collaborations
Scott has collaborated with notable colleagues, including Andrew G. Reaume and Robert Siman, to advance research in his field. Their combined expertise has fostered significant advancements in biomedical research.
Conclusion
Richard W. Scott's contributions to the field of biomedical research, particularly in the context of Alzheimer's disease, highlight his innovative spirit and dedication to improving human health. His patents and collaborations continue to pave the way for future discoveries in this critical area of study.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile